Literature DB >> 25468574

Risk factors for coagulopathy after liver resection.

Tina Ramspoth1, Anna B Roehl1, Stephan Macko1, Cristoph Heidenhain2, Karsten Junge2, Marcel Binnebösel2, Maximilian Schmeding2, Ulf P Neumann2, Rolf Rossaint1, Marc Hein3.   

Abstract

STUDY
OBJECTIVE: To identify risk factors for coagulopathy in patients undergoing liver resection.
DESIGN: A retrospective cohort study.
SETTING: Patients who underwent liver resection at a university hospital between April 2010 and May 2011 were evaluated within seven days after surgery. PATIENTS: One hundred forty-seven patients were assessed for eligibility. Thirty needed to be excluded because of incomplete data (23) or a preexisting coagulopathy (7). MEASUREMENTS: Coagulopathy was defined as 1 or more of the following events: international normalized ratio ≥1.4, platelet count <80,000/μL, and partial thromboplastin time >38 seconds. Related to the time course and coagulation profile thresholds, 3 different groups could be distinguished: no coagulopathy, temporary coagulopathy, and persistent coagulopathy. MAIN
RESULTS: Seventy-seven patients (65.8%) had no coagulopathy, whereas 33 (28.2%) developed temporary coagulopathy and 7 (6%) developed persistent coagulopathy until day 7. Preoperative international normalized ratio (P = .001), postoperative peak lactate levels (P = .012), and resected liver weight (P = .005) were identified as independent predictors. Preoperative liver transaminases and transfusion volumes of red blood cells and fresh frozen plasma were significantly higher in patients with persistent coagulopathy.
CONCLUSIONS: Epidural anesthesia is feasible in patients scheduled for liver resection. Caution should be observed for patients with extended resection (≥3 segments) and increased postoperative lactate. In patients with preexisting liver disease, epidural catheters should be avoided.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Coagulopathy; Epidural anesthesia; Liver resection; Risk factors

Mesh:

Year:  2014        PMID: 25468574     DOI: 10.1016/j.jclinane.2014.08.002

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  5 in total

1.  Effect of epidural compared to patient-controlled intravenous analgesia on outcomes for patients undergoing liver resection for neoplastic disease.

Authors:  Shelby Allen; Amy DeRoche; Lu Adams; Karen Valerie Slocum; Clancy J Clark; Nora F Fino; Perry Shen
Journal:  J Surg Oncol       Date:  2017-02-10       Impact factor: 3.454

2.  Analysis of risk factors affecting coagulopathy after donor hepatectomy in a newly established liver transplant center.

Authors:  Sema Aktaş; Şinasi Sevmiş; Mehmet Şeker; Esin Korkut; Hamdi Karakayalı
Journal:  Turk J Surg       Date:  2017-06-01

3.  Continuous Erector Spinae Plane Block Using Programmed Intermittent Bolus Regimen versus Intravenous Patient-Controlled Opioid Analgesia Within an Enhanced Recovery Program After Open Liver Resection in Patients with Coagulation Disorder: A Randomized, Controlled, Non-Inferiority Trial.

Authors:  Jiali Wang; Fang Du; Yimei Ma; Yuncen Shi; Jie Fang; Jing Xv; Jing Cang; Changhong Miao; Xiaoguang Zhang
Journal:  Drug Des Devel Ther       Date:  2022-09-30       Impact factor: 4.319

4.  Heat Killed Lactobacillus reuteri GMNL-263 Reduces Fibrosis Effects on the Liver and Heart in High Fat Diet-Hamsters via TGF-β Suppression.

Authors:  Wei-Jen Ting; Wei-Wen Kuo; Dennis Jine-Yuan Hsieh; Yu-Lan Yeh; Cecilia-Hsuan Day; Ya-Hui Chen; Ray-Jade Chen; Viswanadha Vijaya Padma; Yi-Hsing Chen; Chih-Yang Huang
Journal:  Int J Mol Sci       Date:  2015-10-28       Impact factor: 5.923

5.  Pre- to postoperative coagulation profile of 307 patients undergoing oesophageal resection with epidural blockade over a 10-year period in a single hospital: implications for the risk of spinal haematoma.

Authors:  Owain Thomas; Emanuel Lybeck; Per Flisberg; Ulf Schött
Journal:  Perioper Med (Lond)       Date:  2017-10-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.